Postoperative radiotherapy results in 192 epithelial thymic tumours patients with 10 years of follow-up

Authors: Lopez, Hugo ^{a, 2}, Botticella, Angela ^{a, 2}, Belkhir, Farid ^{a, 1, 2}, Besse, Benjamin ^{b, c}, Fadel, Elie ^{c, e}, Mercier, Olaf ^{c, e}, Levy, Antonin ^{a, c, d, 3}, Le Péchoux, Cécile ^{a, 3, ⁎}

Source: In Radiotherapy and Oncology June 2024 195

High Response Rate to Carboplatin-Paclitaxel-Cetuximab and Pembrolizumab in Patients with Recurrent and/or Metastatic Head and Neck Squamous Cell Carcinoma.

Authors: Chauffert, Bruno, Zhou, Yuedan, Medjkoune, Liza, Ouikene, Abdenour, Galez, Agnes, Belkhir, Farid, Saint-Germain, Pierre, Youssef, Ali, Chehimi, Mohamad

Source: Case Reports in Oncology; 2023, Vol. 16 Issue 1, p13-20, 8p

Subject Terms: SQUAMOUS cell carcinoma, IMMUNE checkpoint inhibitors, PEMBROLIZUMAB, HEAD & neck cancer, HEPATOTOXICOLOGY, CETUXIMAB

This result is not displayed to guests.
Login for full access.

This result is not displayed to guests.
Login for full access.